More than 20 percent of
migraine patients report that they feel better even when they are given a placebo.
Not exact matches
Patients with temporal - type
migraine derive similar and significant improvement from techniques that relieve pressure on (decompression) or remove a portion of (neurectomy) the nerve responsible for triggering their headaches,
reports the study by ASPS Member Surgeon Bahman Guyuron, MD, Emeritus professor of plastic surgery at Case School of Medicine, Cleveland, and colleagues.
Patients reported the severity of their headaches on a visual analogue scale (VAS), ranging from 1 - 10, to quantify the degree of debilitation experienced from the
migraine.
Occurrence of new - onset
migraine attacks has been
reported in approximately 15 percent of
patients following transcatheter ASD closure, with the majority of initial episodes occurring within the days to weeks following the procedure.
Topamax, an epilepsy drug from Ortho - McNeil Pharmaceutical, has proven extremely effective on
migraines in clinical trials: Half of all
patients have
reported a 50 percent reduction in the frequency of
migraines, and more than a quarter have a
reported 75 percent reduction.
Dr. Oren Tessler, Assistant Professor of Clinical Surgery at LSU Health Sciences Center New Orleans School of Medicine, is part of a team of plastic and reconstructive surgeons who
report a high success rate using a method to screen and select
patients for a specific surgical
migraine treatment technique.